CAALYX

Older people's autonomy and self-confidence can be greatly increased by wearing a light device that measure vital signs, detect falls, and automatically raise an alert to their care centre in case of an emergency.

Europe is about to face a significant social change, brought about by an unprecedented demographic change: the ratio of elderly people to the entire population is steadily growing, while the ratio of younger age groups, especially the working population is shrinking.

CAALYX's main objective is to develop a wearable light device able to measure specific vital signs of the elderly, to detect falls and to communicate automatically in real time with his/her care provider in case of an emergency, wherever the elderly person happens to be, at home or outside.

Specifically, CAALYX' objectives are:

  • To identify which vital signs and patterns are more relevant to determine probable critical states of an elder's health.
  • To develop an electronic device able to measure vital signs and to detect falls of the aged person at the domestic environment and outside. This gadget will have a geolocation system so that the monitoring system may be able to know the elder's position in case of emergency (especially outdoors).
  • To allow for the secure monitoring of individuals organised into groups managed by a caretaker who will decide whether to promote raised events to the emergency service (112).
  • To create social tele-assistance services that can be easily operated by users.

For further information, please visit:
http://www.caalyx.eu

Project co-ordinator:
Telefónica Investigación y Desarrollo SA Unipersonal

Partners:

  • Inesc Porto-Instituto de Engenharia de Sistemas e Computadores do Porto (Portugal)
  • Cooperativa Sociale Cooss Marche Onlus Societa Cooperativa per Azioni (IT)
  • Synkronix Incorporation Limited (UK)
  • University of Plymouth (UK)
  • University of Limerick (Ireland)
  • Fundació Hospital Comarcal Sant Antoni Abat (SP)
  • Corscience Gmbh & Co KG (Germany)

Timetable: 01/01/2007 - 31/12/2008

Total cost: € 2.962.087,23

EC funding: € 1.850.000,00

Instrument: STREP

Project Identifier: IST-2005-045215

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...